Evidence map›Paper›PMID 37415776›Full record

ArticleBrain communications2023

Markers of limbic system damage following SARS-CoV-2 infection.

Marine Thomasson, Philippe Voruz, Alexandre Cionca, Isabele Jacot de Alcântara, Anthony Nuber-Champier, Gilles Allali, Lamyae Benzakour, Patrice H Lalive, Karl-Olof Lövblad, Olivia Braillard and 11 more

Abstract read
In one paragraph

Article in Brain communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Marine ThomassonClinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, Geneva 1205, Switzerland.ORCID https://orcid.org/0000-0002-5213-2924
Philippe VoruzClinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, Geneva 1205, Switzerland.ORCID https://orcid.org/0000-0001-6796-8807
Alexandre CioncaClinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, Geneva 1205, Switzerland.ORCID https://orcid.org/0000-0002-1910-9650
Isabele Jacot de AlcântaraClinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, Geneva 1205, Switzerland.
Anthony Nuber-ChampierClinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, Geneva 1205, Switzerland.
Gilles AllaliLeenaards Memory Centre, Lausanne University Hospital and University of Lausanne, Lausanne 1205, Switzerland.ORCID https://orcid.org/0000-0002-4455-6719
Lamyae BenzakourPsychiatry Department, Geneva University Hospitals, Geneva 1205, Switzerland.
Patrice H LaliveNeurology Department, Department of Clinical Neurosciences, Geneva University Hospitals, Geneva 1205, Switzerland.
Karl-Olof LövbladFaculty of Medicine, University of Geneva, Geneva 1011, Switzerland.
Olivia BraillardDivision and Department of Primary Care Medicine, Geneva University Hospitals, Geneva 1205, Switzerland.
Mayssam NehmeDivision and Department of Primary Care Medicine, Geneva University Hospitals, Geneva 1205, Switzerland.ORCID https://orcid.org/0000-0001-9189-6495
Matteo CoenDivision of General Internal Medicine, Department of Medicine, Geneva University Hospitals and Geneva University, Geneva 1205, Switzerland.
Jacques SerratriceDivision of General Internal Medicine, Department of Medicine, Geneva University Hospitals and Geneva University, Geneva 1205, Switzerland.
Jean-Luc RenyFaculty of Medicine, University of Geneva, Geneva 1011, Switzerland.ORCID https://orcid.org/0000-0002-7528-7363
Jérôme PuginFaculty of Medicine, University of Geneva, Geneva 1011, Switzerland.
Idris GuessousFaculty of Medicine, University of Geneva, Geneva 1011, Switzerland.ORCID https://orcid.org/0000-0002-0491-6089
Basile N LandisFaculty of Medicine, University of Geneva, Geneva 1011, Switzerland.
Alessandra GriffaLeenaards Memory Centre, Lausanne University Hospital and University of Lausanne, Lausanne 1205, Switzerland.
Dimitri Van De VilleFaculty of Medicine, University of Geneva, Geneva 1011, Switzerland.
Frederic AssalNeurology Department, Department of Clinical Neurosciences, Geneva University Hospitals, Geneva 1205, Switzerland.
Julie A PéronClinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, Geneva 1205, Switzerland.ORCID https://orcid.org/0000-0002-6579-4011

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alterations of the limbic system may be present in the chronic phase of SARS-CoV-2 infection. Our aim was to study the long-term impact of this disease on limbic system-related behaviour and its associated brain functional connectivity, according to the severity of respiratory symptoms in the acute phase. To this end, we investigated the multimodal emotion recognition abilities of 105 patients from the Geneva COVID-COG Cohort 223 days on average after SARS-CoV-2 infection (diagnosed between March 2020 and May 2021), dividing them into three groups (severe, moderate or mild) according to respiratory symptom severity in the acute phase. We used multiple regressions and partial least squares correlation analyses to investigate the relationships between emotion recognition, olfaction, cognition, neuropsychiatric symptoms and functional brain networks. Six to 9 months following SARS-CoV-2 infection, moderate patients exhibited poorer recognition abilities than mild patients for expressions of fear (

Indexed as

emotionfunctional connectivityMRIneuropsychological deficitspost-COVID syndrome

Identifiers

PMID37415776
PMCPMC10320753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.